Korea is committed partner in campaign against drug-resistant infections
The misuse and overuse of antimicrobials for years have made bacteria learn how to fight back and build antimicrobial resistance (AMR) that can render drugs ineffective.
The health crisis associated with multidrug resistant bacteria is becoming more serious with COVID-19, as more antibiotics are being used to treat coronavirus-infected patients.
The slowly-developing nature of AMR can be more fatal than COVID-19 because it evolves into the “next pandemic” while being unnoticed by the public, according to International Centre for Antimicrobial Resistance Solutions (ICARS) Director of Operations Helle Engslund Krarup.
In a written interview with The Korea Times this month, Krarup accordingly thanked Korea for its commitment to the campaign against AMR even before COVID-19 raised awareness of it.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!